Pharmaceutical exports a rare bright spot for Singapore economy
Singapore
SINGAPORE'S exports of pharmaceutical products have surged this year as the coronavirus pandemic prompts worldwide stockpiling of drug ingredients, providing a much needed salve for an economy facing its deepest recession in its 55-year history.
Pharmaceutical output in Singapore has spiked 86 per cent so far this year, official data showed on Tuesday, while export data for April showed that pharmaceutical shipments surged 174 per cent from the same month a year earlier, albeit from a low base.
Singapore is one of the few countries in the world that exports more pharmaceuticals than it imports, according to Fitch Solutions. It has more than 50 pharmaceutical manufacturing facilities, including plants owned by eight of the world's 10 biggest pharma firms.
Companies and governments around the world are building large inventories of active pharmaceutical ingredients (APIs) and drugs to ensure supplies of medicine remain uninterrupted and can be made close to market, said How Ti Hwei, president of the Singapore Association of Pharmaceutical Industries.
"Across the board there is stocking up," he said.
A NEWSLETTER FOR YOU
Asean Business
Business insights centering on South-east Asia's fast-growing economies.
Mr How said the pandemic has driven up demand for intensive care and emergency-use drugs, including antibiotics and anaesthesia products. The United States, Europe and Japan were Singapore's biggest export destinations for APIs in recent months, he added.
US drugmaker Pfizer said in a statement that it had seen a "tremendous increase in demand" for anti-infectives - a generic term for drugs such as antibiotics and antivirals used to treat infections - which it produces in Singapore and elsewhere.
The beefing up of drug inventories has helped lift exports from Singapore for three straight months, defying analysts' forecasts that overall shipments would fall.
Its biomedical industry, which employs more than 24,000 people, accounted for about 20 per cent of the manufacturing sector in 2019 which in turn accounted for about a fifth of gross domestic product. REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife customers push for legal action